Skip to main content
Journal cover image

Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.

Publication ,  Journal Article
Nelson, JE; Brunt, EM; Kowdley, KV; Nonalcoholic Steatohepatitis Clinical Research Network,
Published in: Hepatology
November 2012

UNLABELLED: Hepcidin regulation is linked to both iron and inflammatory signals and may influence iron loading in nonalcoholic steatohepatitis (NASH). The aim of this study was to examine the relationships among HFE genotype, serum hepcidin level, hepatic iron deposition, and histology in nonalcoholic fatty liver disease (NAFLD). Single-nucleotide polymorphism genotyping for C282Y (rs1800562) and H63D (rs1799945) HFE mutations was performed in 786 adult subjects in the NASH Clinical Research Network (CRN). Clinical, histologic, and laboratory data were compared using nonparametric statistics and multivariate logistic regression. NAFLD patients with C282Y, but not H63D mutations, had lower median serum hepcidin levels (57 versus 65 ng/mL; P = 0.01) and higher mean hepatocellular (HC) iron grades (0.59 versus 0.28; P < 0.001), compared to wild-type (WT) subjects. Subjects with hepatic iron deposition had higher serum hepcidin levels than subjects without iron for all HFE genotypes (P < 0.0001). Hepcidin levels were highest among patients with mixed HC/reticuloendothelial system cell (RES) iron deposition. H63D mutations were associated with higher steatosis grades and NAFLD activity scores (odds ratio [OR], ≥1.4; 95% confidence interval [CI]: >1.0, ≤2.5; P ≤ 0.041), compared to WT, but not with either HC or RES iron. NAFLD patients with C282Y mutations had less ballooning or NASH (OR, ≤0.62; 95% CI: >0.39, <0.94; P ≤ 0.024), compared to WT subjects. CONCLUSIONS: The presence of C282Y mutations in patients with NAFLD is associated with greater HC iron deposition and decreased serum hepcidin levels, and there is a positive relationship between hepatic iron stores and serum hepcidin level across all HFE genotypes. These data suggest that body iron stores are the major determinant of hepcidin regulation in NAFLD, regardless of HFE genotype. A potential role for H63D mutations in NAFLD pathogenesis is possible through iron-independent mechanisms.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Hepatology

DOI

EISSN

1527-3350

Publication Date

November 2012

Volume

56

Issue

5

Start / End Page

1730 / 1740

Location

United States

Related Subject Headings

  • Statistics, Nonparametric
  • Polymorphism, Single Nucleotide
  • Odds Ratio
  • Non-alcoholic Fatty Liver Disease
  • Mutation
  • Multivariate Analysis
  • Mononuclear Phagocyte System
  • Middle Aged
  • Membrane Proteins
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nelson, J. E., Brunt, E. M., Kowdley, K. V., & Nonalcoholic Steatohepatitis Clinical Research Network, . (2012). Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations. Hepatology, 56(5), 1730–1740. https://doi.org/10.1002/hep.25856
Nelson, James E., Elizabeth M. Brunt, Kris V. Kowdley, and Kris V. Nonalcoholic Steatohepatitis Clinical Research Network. “Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.Hepatology 56, no. 5 (November 2012): 1730–40. https://doi.org/10.1002/hep.25856.
Nelson JE, Brunt EM, Kowdley KV, Nonalcoholic Steatohepatitis Clinical Research Network. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations. Hepatology. 2012 Nov;56(5):1730–40.
Nelson, James E., et al. “Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.Hepatology, vol. 56, no. 5, Nov. 2012, pp. 1730–40. Pubmed, doi:10.1002/hep.25856.
Nelson JE, Brunt EM, Kowdley KV, Nonalcoholic Steatohepatitis Clinical Research Network. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations. Hepatology. 2012 Nov;56(5):1730–1740.
Journal cover image

Published In

Hepatology

DOI

EISSN

1527-3350

Publication Date

November 2012

Volume

56

Issue

5

Start / End Page

1730 / 1740

Location

United States

Related Subject Headings

  • Statistics, Nonparametric
  • Polymorphism, Single Nucleotide
  • Odds Ratio
  • Non-alcoholic Fatty Liver Disease
  • Mutation
  • Multivariate Analysis
  • Mononuclear Phagocyte System
  • Middle Aged
  • Membrane Proteins
  • Male